We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBL icon
101
Jabil
JBL
$32.4B
$41.8M 0.2%
348,567
+77,408
+29% +$8.41M
USMV icon
102
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
$41M 0.2%
449,459
-9,497
-2% -$837K
RWO icon
103
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$40M 0.19%
840,807
-14,239
-2% -$643K
TXN icon
104
Texas Instruments
TXN
$255B
$39.8M 0.19%
192,621
+228
+0.1% +$45.8K
WSM icon
105
Williams-Sonoma
WSM
$27.5B
$39.4M 0.19%
254,394
+32,288
+15% +$4.63M
PGR icon
106
Progressive
PGR
$125B
$39.4M 0.19%
155,215
-261,865
-63% -$60.9M
VTV icon
107
Vanguard Value ETF
VTV
$189B
$38.9M 0.19%
222,645
+6,896
+3% +$1.15M
WDAY icon
108
Workday
WDAY
$36.7B
$38M 0.18%
155,344
+6,368
+4% +$1.5M
OKTA icon
109
Okta
OKTA
$24B
$38M 0.18%
510,658
+76,588
+18% +$6.69M
IBM icon
110
IBM
IBM
$204B
$37.6M 0.18%
170,277
-603
-0.4% -$118K
PINS icon
111
Pinterest
PINS
$13.3B
$36.7M 0.18%
1,134,161
-1,007
-0.1% -$34.2K
CI icon
112
Cigna
CI
$77.2B
$36.2M 0.17%
104,547
-22,997
-18% -$7.92M
EMLP icon
113
First Trust North American Energy Infrastructure Fund
EMLP
$4.13B
$36.1M 0.17%
1,073,042
-11,537
-1% -$371K
MRSH
114
Marsh
MRSH
$87.6B
$36M 0.17%
161,337
-2,733
-2% -$607K
COP icon
115
ConocoPhillips
COP
$142B
$35.5M 0.17%
337,449
+14,030
+4% +$1.54M
BAC icon
116
Bank of America
BAC
$436B
$35.4M 0.17%
891,747
+57,822
+7% +$2.32M
NVO
117
Novo Nordisk
NVO
$220B
$35.2M 0.17%
295,430
-5,143
-2% -$686K
ULTA icon
118
Ulta Beauty
ULTA
$20.7B
$35.2M 0.17%
90,391
+77
+0.1% +$28.9K
FISV
119
Fiserv Inc
FISV
$27.9B
$35.1M 0.17%
195,285
+6,985
+4% +$1.15M
ON icon
120
ON Semiconductor
ON
$34.7B
$34.9M 0.17%
481,122
+22,429
+5% +$1.63M
WAT icon
121
Waters Corp
WAT
$36.5B
$34.9M 0.17%
97,007
-1,268
-1% -$413K
PPG icon
122
PPG Industries
PPG
$26.4B
$34.9M 0.17%
263,455
-12,689
-5% -$1.6M
P
123
Everpure Inc
P
$24.6B
$34.3M 0.16%
683,464
+190,225
+39% +$10.8M
MDT icon
124
Medtronic
MDT
$108B
$34.3M 0.16%
380,554
+90,111
+31% +$7.58M
SNA icon
125
Snap-on
SNA
$21B
$34M 0.16%
117,469
-1,769
-1% -$488K
3 4
5
6 7

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.